Skip to main content
Log in

Perioperative Aspekte der Herztransplantation

  • Leitthema
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Seit über 20 Jahren wird die orthotope Herztransplantation zur Therapie von Patienten mit terminaler Herzerkrankung eingesetzt. Die perioperative Betreuung dieser Patienten ist eine Herausforderung für den Anästhesisten. Zunächst muss es gelingen, einen Patienten mit terminaler Herzinsuffizienz, Herzrhythmusstörungen und oftmals multiplen Voroperationen sicher an die Herz-Lungen-Maschine anzuschließen. Danach ist selbst bei einer unproblematischen Durchführung der eigentlichen Transplantation und kurzer Ischämiezeit der Abgang von der Herz-Lungen-Maschine häufig erschwert. Der rechte Ventrikel des Spenderorgans ist in vielen Fällen nicht an den pulmonalen Gefäßwiderstand des Empfängers angepasst. Bei vorbestehender pulmonaler Hypertonie des Empfängers entwickelt sich oft eine akute Rechtsherzinsuffizienz. Zur Therapie des akuten Rechtsherzversagens gehören die Senkung des pulmonalen Gefäßwiderstands und die Verbesserung der rechtsventrikulären Pumpfunktion. Der Einsatz der transösophagealen Echokardiographie (TEE) ermöglicht die frühzeitige Diagnose und Therapiekontrolle des akuten Rechtsherzversagens. Darüber hinaus können wichtige Differenzialdiagnosen, wie beispielsweise ein Abknicken der pulmonalen Anastomose oder eine Klappeninsuffizienz im Spenderorgan (z. B. Trikuspidalinsuffizienz), erkannt werden. Neben der Betreung von Patienten, die sich einer Herztransplantation unterziehen, gehört auch die perioperative Versorgung von Patienten nach Herztransplantation zu den Aufgaben des Anästhesisten. Die Kenntnis der physiologischen und pharmakologischen Besonderheiten dieser Patientengruppe ist hierbei von entscheidender Bedeutung.

Abstract

Over the past 30 years, heart transplantation has evolved into a definitive therapy for patients with end-stage cardiomyopathy. However, perioperative management of patients undergoing heart transplantation remains a challenge for anesthesiologists. The presence of biventricular failure, arrhythmias and associated multisystem organ dysfunction may contribute to significant intraoperative hemodynamic instability prior to the initiation of cardiopulmonary bypass (CPB). Even after an uneventful transplantation, weaning from CPB may be difficult. Acute right ventricular failure can develop in the recipient secondary to pre-existing pulmonary hypertension. Treatment options frequently focus on therapeutic interventions directed towards decreasing pulmonary vascular resistance and improving right ventricular contractility. Intraoperative use of transesophageal echocardiography (TEE) enables the anesthesiologist to diagnose acute right ventricular failure early on and guide therapy. Concurrent pathology including kinking of the pulmonary artery anastomosis or valvular insufficiency in the transplanted heart can also be recognized and addressed. The number of patients undergoing cardiac transplantation is continually increasing. In addition, the use of more effective immunosuppressive agents has curtailed transplant rejection and permitted longer survival. Consequently, heart transplant recipients are more frequently presenting for non-cardiac surgical procedures. Thus, an understanding of physiological and pharmacological implications associated with heart transplantation is crucial for managing these patients in the perioperative period.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1.
Abb. 2.
Abb. 3.
Abb. 4.

Literatur

  1. Addonizio LJ, Gersony WM, Robbins RC et al. (1987) Elevated pulmonary vascular resistance and cardiac transplantation. Circulation 76:V52–55

    CAS  PubMed  Google Scholar 

  2. Anyanwu AC, Rogers CA, Murday AJ (2002) Intrathoracic organ transplantation in the United Kingdom 1995–99: results from the UK cardiothoracic transplant audit. Heart 87:449–454

    Article  CAS  PubMed  Google Scholar 

  3. Arafa OE, Geiran OR, Andersen K, Fosse E, Simonsen S, Svennevig JL (2000) Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 70:1587–1593

    Article  CAS  PubMed  Google Scholar 

  4. Arrowood JA, Minisi AJ, Goudreau E, Davis AB, King AL (1997) Absence of parasympathetic control of heart rate after human orthotopic cardiac transplantation. Circulation 96:3492–3498

    CAS  PubMed  Google Scholar 

  5. Aziz TM, Burgess MI, El-Gamel A, Campbell CS, Rahman AN, Deiraniya AK, Yonan NA (1999) Orthotopic cardiac transplantation technique: a survey of current practice. Ann Thorac Surg 68:1242–1246

    Article  CAS  PubMed  Google Scholar 

  6. Backman SB, Ralley FE, Fox GS (1993) Neostigmine produces bradycardia in a heart transplant patient. Anesthesiology 78:777–779

    CAS  PubMed  Google Scholar 

  7. Backman SB, Stein RD, Ralley FE, Fox GS (1996) Neostigmine-induced bradycardia following recent vs remote cardiac transplantation in the same patient. Can J Anaesth 43:394–398

    CAS  PubMed  Google Scholar 

  8. Baldwin JC, Anderson JL, Boucek MM, Bristow MR, Jennings B, Ritsch ME, Silverman NA (1993) 24th Bethesda conference: Cardiac transplantation. Task Force 2: Donor guidelines. J Am Coll Cardiol 22:15–20

    CAS  PubMed  Google Scholar 

  9. Baldwin RT, Duncan JM, Frazier OH, Wilansky S (1991) Patent foramen ovale: a cause of hypoxemia in patients on left ventricular support. Ann Thorac Surg 52:865–867

    PubMed  Google Scholar 

  10. Bando K, Konishi H, Komatsu K et al. (1993) Improved survival following pediatric cardiac transplantation in high-risk patients. Circulation 88:II218–223

    PubMed  Google Scholar 

  11. Barnard CN (1967) The operation. A human cardiac transplant: an interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 41:1271–1274

    PubMed  Google Scholar 

  12. Barnard CN (1968) What we have learned about heart transplants. J Thorac Cardiovasc Surg 56:457–468

    PubMed  Google Scholar 

  13. Barnard SP, Hasan A, Forty J, Hilton CJ, Dark JH (1995) Mechanical ventricular assistance for the failing right ventricle after cardiac transplantation. Eur J Cardiothorac Surg 9:297–299

    CAS  PubMed  Google Scholar 

  14. Baumgartner WA, Traill TA, Cameron DE, Fonger JD, Birenbaum IB, Reitz BA (1989) Unique aspects of heart and lung transplantation exhibited in the 'domino-donor' operation. JAMA 261:3121–3125

    Article  PubMed  Google Scholar 

  15. Beebe DS, Shumway SJ, Maddock R (1994) Sinus arrest after intravenous neostigmine in two heart transplant recipients. Anesth Analg 78:779–782

    PubMed  Google Scholar 

  16. Bengel FM, Ueberfuhr P, Schiepel N, Nekolla SG, Reichart B, Schwaiger M (2001) Effect of sympathetic reinnervation on cardiac performance after heart transplantation. N Engl J Med 345:731–738

    Article  PubMed  Google Scholar 

  17. Beniaminovitz A, Itescu S, Lietz K et al. (2000) Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 342:613–619

    CAS  PubMed  Google Scholar 

  18. Bjerke RJ, Mangione MP (2001) Asystole after intravenous neostigmine in a heart transplant recipient. Can J Anaesth 48:305–307

    PubMed  Google Scholar 

  19. Borel JF, Feurer C, Gubler HU, Stahelin H (1976) Biological effects of cyclosporin A: a new antilymphocytic agent. Agents Actions 6:468–475

    CAS  PubMed  Google Scholar 

  20. Borel JF, Feurer C, Magnee C, Stahelin H (1977) Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 32:1017–1025

    PubMed  Google Scholar 

  21. Borow KM, Neumann A, Arensman FW, Yacoub MH (1989) Cardiac and peripheral vascular responses to adrenoceptor stimulation and blockade after cardiac transplantation. J Am Coll Cardiol 14:1229–1238

    PubMed  Google Scholar 

  22. Bourge RC, Naftel DC, Costanzo-Nordin MR et al. (1993) Pretransplantation risk factors for death after heart transplantation: a multiinstitutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant 12:549–562

    CAS  PubMed  Google Scholar 

  23. Brandt M, Harringer W, Hirt SW, Walluscheck KP, Cremer J, Sievers HH, Haverich A (1997) Influence of bicaval anastomoses on late occurrence of atrial arrhythmia after heart transplantation. Ann Thorac Surg 64:70–72

    Article  PubMed  Google Scholar 

  24. Brunner-La Rocca HP, Weilenmann D, Bracht C, Carli S, Schlumpf M, Follath F, Kiowski W (1998) Relative frequency of functional sympathetic and parasympathetic reinnervation after heart transplantation. J Heart Lung Transplant 17:725–728

    PubMed  Google Scholar 

  25. Bundesärztekammer (2001) Richtlinien für die Warteliste zur Herz-, Herz-Lungen- und Lungentransplantation (thorakale Organtransplantationen). Erste Fortschreibung 2001.http://www.bundesaerztekammer.de/30/Richtlinien/Richtidx/Organ/10Organtrans/30WarteHerz.html

  26. Canivet JL, Defraigne JO, Demoulin JC, Limet R (1994) Mechanical flow obstruction after heart transplantation diagnosed by TEE. Ann Thorac Surg 58:890–891

    PubMed  Google Scholar 

  27. Cannom DS, Graham AF, Harrison DC (1973) Electrophysiological studies in the denervated transplanted human heart. Response to trial pacing and atropine. Circ Res 23:268–278

    Google Scholar 

  28. Cannom DS, Rider AK, Sinson EB et al. (1973) Electrophysiological studies in the denervated transplanted human heart. II. Response to norepinephrine, isoproterenol and propanolol. Am J Cardiol 36:859–866

    Google Scholar 

  29. Cantin B, Wen P, Zhu D et al. (2001) Transplant coronary artery disease: a novel model independent of cellular alloimmune response. Circulation 104:2615–2619

    PubMed  Google Scholar 

  30. Caparrelli DJ, Shake JG, Cattaneo SM 2nd, Chang BY, Baumgartner WA, Conte JV Jr, George P (2002) Heterotopic abdominal heart transplantation: a pilot study. Curr Opin Cardiol 17:145–151

    Article  PubMed  Google Scholar 

  31. Chatel D, Paquin S, Oroudji M, Provenchere S, Plantefeve G, Philip I (1999) Systolic anterior motion of the anterior mitral leaflet after heart transplantation. Anesthesiology 91:1535–1537

    PubMed  Google Scholar 

  32. Chen EP, Bittner HB, Davis RD, Trigt P van (1997) Effects of nitric oxide after cardiac transplantation in the setting of recipient pulmonary hypertension. Ann Thorac Surg 63:1546–1555

    Article  PubMed  Google Scholar 

  33. Chen EP, Bittner HB, Davis RD, Trigt P van (1997) Milrinone improves pulmonary hemodynamics and right ventricular function in chronic pulmonary hypertension. Ann Thorac Surg 63:814–821

    Article  PubMed  Google Scholar 

  34. Chen EP, Bittner HB, Davis RD, Trigt P van (1997) Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension. J Surg Res 69:288–294

    Article  PubMed  Google Scholar 

  35. Chen EP, Bittner HB, Tull F, Craig D, Davis RD, Trigt P van (1997) Nitric oxide improves pulmonary vascular impedance, transpulmonary efficiency, and left ventricular filling in chronic pulmonary hypertension. J Thorac Cardiovasc Surg 113:849–857

    PubMed  Google Scholar 

  36. Chen EP, Bittner HB, Davis RD, Trigt P van (1998) Hemodynamic and inotropic effects of milrinone after heart transplantation in the setting of recipient pulmonary hypertension. J Heart Lung Transplant 17:669–678

    PubMed  Google Scholar 

  37. Chen EP, Craig DM, Bittner HB, Davis RD, Trigt P van (1998) Pharmacological strategies for improving diastolic dysfunction in the setting of chronic pulmonary hypertension. Circulation 97:1606–1612

    PubMed  Google Scholar 

  38. Chen JM, Levin HR, Rose EA et al. (1996) Experience with right ventricular assist devices for perioperative right-sided circulatory failure. Ann Thorac Surg 61:305–310; discussion 311–313

    Article  CAS  PubMed  Google Scholar 

  39. Cheong KF, Choy JM (2000) Sevoflurane-fentanyl versus etomidate-fentanyl for anesthetic induction in coronary artery bypass graft surgery patients. J Cardiothorac Vasc Anesth 14:421–424

    Article  CAS  PubMed  Google Scholar 

  40. Colon R, Frazier OH, Kahan BD, Radovancevic B, Duncan JM, Lorber MI, Buren CT van (1988) Complications in cardiac transplant patients requiring general surgery. Surgery 103:32–38

    CAS  PubMed  Google Scholar 

  41. Copeland JG, Emery RW, Levinson MM, Copeland J, McAleer MJ, Riley JE (1985) The role of mechanical support and transplantation in treatment of patients with end-stage cardiomyopathy. Circulation 72:II7–12

    CAS  PubMed  Google Scholar 

  42. Costanzo-Nordin MR, O'Connell JB, Engelmeier RS, Moran JF, Scanlon PJ (1985) Dilated cardiomyopathy: functional status, hemodynamics, arrhythmias, and prognosis. Cathet Cardiovasc Diagn 11:445–453

    CAS  PubMed  Google Scholar 

  43. Costard-Jackle A, Fowler MB (1992) Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol 19:48–54

    CAS  PubMed  Google Scholar 

  44. Dajani AS, Taubert KA, Wilson W et al. (1997) Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 277:1794–1801

    Article  CAS  PubMed  Google Scholar 

  45. Dajani AS, Taubert KA, Wilson W et al. (1997) Prevention of bacterial endocarditis. Recommendations by the American Heart Association. Circulation 96:358–366

    CAS  PubMed  Google Scholar 

  46. Darrah WC, Sharpe MD, Guiraudon GM, Neal A (1997) Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload. Ann Thorac Surg 64:1718–1723; discussion 1723–1724

    Article  PubMed  Google Scholar 

  47. Del Rizzo DF, Menkis AH, Pflugfelder PW, Novick RJ, McKenzie FN, Boyd WD, Kostuk WJ (1999) The role of donor age and ischemic time on survival following orthotopic heart transplantation. J Heart Lung Transplant 18:310–319

    Article  PubMed  Google Scholar 

  48. Deng MC, De Meester JM, Smits JM, Heinecke J, Scheld HH (2000) Effect of receiving a heart transplant: analysis of a national cohort entered on to a waiting list, stratified by heart failure severity. Comparative Outcome and Clinical Profiles in Transplantation (COCPIT) Study Group. BMJ 321:540–545

    Article  PubMed  Google Scholar 

  49. Dreyfus G, Jebara VA, Couetil JP, Carpentier A (1990) Kinking of the pulmonary artery: a treatable cause of acute right ventricular failure after heart transplantation. J Heart Transplant 9:575–576

    PubMed  Google Scholar 

  50. Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN (1993) Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group. Circulation 87 [Suppl 6]:VI94–101

  51. Edrich T, Shernan SK, Smith B, Eltzschig HK (2003) Usefulness of intraoperative epiaortic echocardiography to resolve discrepancy between transthoracic and transesophageal measurements of aortic valve gradient. Can J Anaesth 50:293–296

    PubMed  Google Scholar 

  52. Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB (1990) Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity. Circulation 81:821–828

    PubMed  Google Scholar 

  53. Eltzschig HK, Goetz AE, Schroeder TH, Ehlers R, Felbinger TW (2002) Transesophageal echocardiography: perioperative evaluation of valvular function. Anaesthesist 51:81–102

    Article  Google Scholar 

  54. Eltzschig HK, Mihaljevic T, Byrne JG, Ehlers R, Smith B, Shernan SK (2002) Echocardiographic evidence of right ventricular remodeling after transplantation. Ann Thorac Surg 74:584–586

    Article  PubMed  Google Scholar 

  55. Eltzschig HK, Kallmeyer I, Mihaljevic T, Alapati S, Shernan SK (2003) A practical approach to a comprehensive epicardial echocardiographic examination. J Cardiothorac Vasc Anesth (in press)

  56. Evans RW, Manninen DL, Garrison LP, Maier AM (1986) Donor availability as the primary determinant of the future of heart transplantation. JAMA 255:1892–1898

    Article  PubMed  Google Scholar 

  57. Falk RH, Foster E, Coats MH (1992) Ventricular thrombi and thromboembolism in dilated cardiomyopathy: a prospective follow-up study. Am Heart J 123:136–142

    PubMed  Google Scholar 

  58. Fazia RB, Mills RM, Conti CR, Staples ED (1996) Aortic valve endocarditis in an acutely rejecting orthotopic heart transplant recipient. Clin Cardiol 19:672–674

    PubMed  Google Scholar 

  59. First International Congress on Cyclosporine. May 16–19, 1983, Houston, Texas. (1983) Transplant Proc 15:2207–3187

    PubMed  Google Scholar 

  60. Fischer S, Strueber M, Haverich A (2000) Clinical cardiac and pulmonary transplantation: the Hannover experience. Clin Transplant:311–316

    Google Scholar 

  61. Fong SW, Qaqundah BY, Taylor WF (1974) Developmental patterns of ABO isoagglutinins in normal children correlated with the effects of age, sex, and maternal isoagglutinins. Transfusion 14:551–559

    PubMed  Google Scholar 

  62. Frenk VE, Shernan SK, Eltzschig HK (2003) Epicardial echocardiography: diagnostic utility for evaluating aortic valve disease during coronary surgery. J Clin Anesth (in press)

    Google Scholar 

  63. Fullerton DA, Kirson LE, St Cyr JA, Albert JD, Whitman GJ (1993) The influence of respiratory acid-base status on adult pulmonary vascular resistance before and after cardiopulmonary bypass. Chest 103:1091–1095

    PubMed  Google Scholar 

  64. Fullerton DA, Kirson LE, St Cyr JA, Kinnard T, Whitman GJ (1993) Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operation. J Thorac Cardiovasc Surg 106:528–536

    PubMed  Google Scholar 

  65. Fullerton DA, McIntyre RC, Kirson LE, St Cyr JA, Whitman GJ, Grover FL (1996) Impact of respiratory acid-base status in patients with pulmonary hypertension. Ann Thorac Surg 61:696–701

    Article  PubMed  Google Scholar 

  66. Gao SZ, Schroeder JS, Hunt SA, Billingham ME, Valantine HA, Stinson EB (1989) Acute myocardial infarction in cardiac transplant recipients. Am J Cardiol 64:1093–1097

    PubMed  Google Scholar 

  67. Ghignone M, Girling L, Prewitt RM (1984) Volume expansion versus norepinephrine in treatment of a low cardiac output complicating an acute increase in right ventricular afterload in dogs. Anesthesiology 60:132–135

    PubMed  Google Scholar 

  68. Gieraerts R, Schertz C, Ghignone M (1989) Right ventricular failure after heart transplantation caused by a kink in the pulmonary artery anastomosis. J Cardiothorac Anesth 3:470–472

    PubMed  Google Scholar 

  69. Girard C, Fargnoli JM, Godin-Ribuot D, Dutheil V, Maitrasse B, Girardet P, Arvieux CC (1996) Inhaled nitric oxide: effects on hemodynamics, myocardial contractility, and regional blood flow in dogs with mechanically induced pulmonary artery hypertension. J Heart Lung Transplant 15:700–708

    PubMed  Google Scholar 

  70. Goldstein DJ, Oz MC, Rose EA (1998) Implantable left ventricular assist devices. N Engl J Med 339:1522–1533

    PubMed  Google Scholar 

  71. Grande AM, Rinaldi M, D'Armini AM et al. (2000) Orthotopic heart transplantation: standard versus bicaval technique. Am J Cardiol 85:1329–1333

    Article  PubMed  Google Scholar 

  72. Grant SC, Khan MA, Faragher EB, Yonan N, Brooks NH (1995) Atrial arrhythmias and pacing after orthotopic heart transplantation: bicaval versus standard atrial anastomosis. Br Heart J 74:149–153

    PubMed  Google Scholar 

  73. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566

    PubMed  Google Scholar 

  74. Greilich PE, Carr ME, Carr SL, Chang AS (1995) Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth Analg 80:459–465

    PubMed  Google Scholar 

  75. Greilich PE, Brouse CF, Beckham J, Jessen ME, Martin EJ, Carr ME (2002) Reductions in platelet contractile force correlate with duration of cardiopulmonary bypass and blood loss in patients undergoing cardiac surgery. Thromb Res 105:523–529

    Article  PubMed  Google Scholar 

  76. Gridelli B, Remuzzi G (2000) Strategies for making more organs available for transplantation. N Engl J Med 343:404–410

    Google Scholar 

  77. Grondin CM, Pomar JL, Hebert Y, Bosch X, Santos JM, Enjalbert M, Campeau L (1984) Reoperation in patients with patent atherosclerotic coronary vein grafts. A different approach to a different disease. J Thorac Cardiovasc Surg 87:379–385

    PubMed  Google Scholar 

  78. Halle AA, Di Sciascio G, Massin EK et al. (1995) Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 26:120–128

    Article  PubMed  Google Scholar 

  79. Hillman ND, Cheifetz IM, Craig DM, Smith PK, Ungerleider RM, Meliones JN (1997) Inhaled nitric oxide, right ventricular efficiency, and pulmonary vascular mechanics: selective vasodilation of small pulmonary vessels during hypoxic pulmonary vasoconstriction. J Thorac Cardiovasc Surg 113:1006–1013

    CAS  PubMed  Google Scholar 

  80. Hoffmeister KM, Felbinger TW, Falet H et al. (2003) The clearance mechanism of chilled blood platelets. Cell 112:87–97

    CAS  PubMed  Google Scholar 

  81. Hosenpud JD (1999) Coronary artery disease after heart transplantation and its relation to cytomegalovirus. Am Heart J 138:S469–472

    CAS  PubMed  Google Scholar 

  82. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ (2001) The Registry of the International Society for Heart and Lung Transplantation: eighteenth Official Report-2001. J Heart Lung Transplant 20:805–815

    Article  CAS  PubMed  Google Scholar 

  83. Huisman AM, Schalm SW, Simoons ML, Laird-Meeter K, Weimar W (1989) Disturbed liver function in heart transplantation candidates: two case reports. Neth J Med 35:33–37

    CAS  PubMed  Google Scholar 

  84. Hunt BJ, Sack D, Amin S, Yacoub MH (1992) The perioperative use of blood components during heart and heart-lung transplantation. Transfusion 32:57–62

    Article  CAS  PubMed  Google Scholar 

  85. Jacquet L, Ziady G, Stein K, Griffith B, Armitage J, Hardesty R, Kormos R (1990) Cardiac rhythm disturbances early after orthotopic heart transplantation: prevalence and clinical importance of the observed abnormalities. J Am Coll Cardiol 16:832–837

    PubMed  Google Scholar 

  86. Kapadia SR, Ziada KM, L'Allier PL et al. (2000) Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. J Heart Lung Transplant 19:167–172

    Article  CAS  PubMed  Google Scholar 

  87. Karck M, Haverich A (1994) Heart transplantation under coumarin therapy: friend or foe? Eur J Anaesthesiol 11:475–479

    Google Scholar 

  88. Klima UP, Guerrero JL, Vlahakes GJ (1999) Myocardial perfusion and right ventricular function. Ann Thorac Cardiovasc Surg 5:74–80

    CAS  PubMed  Google Scholar 

  89. Kunst H, Paruchuru PK, Madden B (2001) Bacterial endocarditis: a rare complication following orthotopic cardiac transplantation. J Heart Lung Transplant 20:483–485

    Article  PubMed  Google Scholar 

  90. Laffel G, Barnett A, Finkelstein S, Kaye M (1992) The relation between experience and outcome in heart transplantation. N Engl J Med 327:1220–1225

    PubMed  Google Scholar 

  91. Langer F, Wendler O, Wilhelm W, Tscholl D, Schafers HJ (2001) Treatment of a case of acute right heart failure by inhalation of iloprost, a long-acting prostacyclin analogue. Eur J Anaesthesiol 18:770–773

    Article  PubMed  Google Scholar 

  92. Levy JH, Bailey JM, Deeb GM (2002) Intravenous milrinone in cardiac surgery. Ann Thorac Surg 73:325–330

    Article  PubMed  Google Scholar 

  93. Lower RR, Stofer RC, Shumway NE (1961) Homovital transplantation of the heart. J Thorac Cardiovasc Surg 41:196–204

    CAS  Google Scholar 

  94. Luke RG (1991) Mechanism of cyclosporine-induced hypertension. Am J Hypertens 4:468–471

    CAS  PubMed  Google Scholar 

  95. Lurie KG, Bristow MR, Reitz BA (1983) Increased beta-adrenergic receptor density in an experimental model of cardiac transplantation. J Thorac Cardiovasc Surg 86:195–201

    PubMed  Google Scholar 

  96. Mancini D (1997) Surgically denervated cardiac transplant. Rewired or permanently unplugged? Circulation 96:6–8

    Google Scholar 

  97. Marchena E, Futterman L de, Wozniak P, Madrid W, Mitrani A, Myerburg RJ, Bolooki H (1989) Pulmonary artery torsion: a potentially lethal complication after orthotopic heart transplantation. J Heart Transplant 8:499–502

    PubMed  Google Scholar 

  98. Mercat A, Diehl JL, Meyer G, Teboul JL, Sors H (1999) Hemodynamic effects of fluid loading in acute massive pulmonary embolism. Crit Care Med 27:540–544

    Google Scholar 

  99. Milano CA, Patel VS, Smith PK, Smith MS (2002) Risk of anaphylaxis from aprotinin re-exposure during LVAD removal and heart transplantation. J Heart Lung Transplant 21:1127–1130

    Article  PubMed  Google Scholar 

  100. Miniati DN, Robbins RC (2001) Techniques in orthotopic cardiac transplantation: a review. Cardiol Rev 9:131–136

    PubMed  Google Scholar 

  101. Miniati DN, Robbins RC (2002) Heart transplantation: a thirty-year perspective. Annu Rev Med 53:189–205

    Article  PubMed  Google Scholar 

  102. Miyamoto Y, Curtiss EI, Kormos RL, Armitage JM, Hardesty RL, Griffith BP (1990) Bradyarrhythmia after heart transplantation. Incidence, time course, and outcome. Circulation 82:IV313–317

    PubMed  Google Scholar 

  103. Molloy WD, Lee KY, Girling L, Schick U, Prewitt RM (1984) Treatment of shock in a canine model of pulmonary embolism. Am Rev Respir Dis 130:870–874

    PubMed  Google Scholar 

  104. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012

    CAS  PubMed  Google Scholar 

  105. Morris D, Mulvihill D, Lew WY (1987) Risk of developing complete heart block during bedside pulmonary artery catheterization in patients with left bundle-branch block. Arch Intern Med 147:2005–2010

    Article  PubMed  Google Scholar 

  106. Morrow WR, Naftel D, Chinnock R et al. (1997) Outcome of listing for heart transplantation in infants younger than six months: predictors of death and interval to transplantation. The Pediatric Heart Transplantation Study Group. J Heart Lung Transplant 16:1255–1266

    PubMed  Google Scholar 

  107. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML, the Multicenter Automatic Defibrillator Implantation Trial II Investigators (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883

    Article  PubMed  Google Scholar 

  108. Mudge GH, Goldstein S, Addonizio LJ et al. (1993) 24th Bethesda conference: Cardiac transplantation. Task Force 3: Recipient guidelines/prioritization. J Am Coll Cardiol 22:21–31

    PubMed  Google Scholar 

  109. Myles PS, Leong CK, Weeks AM et al. (1997) Early hemodynamic effects of left atrial administration of epinephrine after cardiac transplantation. Anesth Analg 84:976–981

    PubMed  Google Scholar 

  110. Organspende und Transplantation in Deutschland (2000) Deutsche Stiftung Organtransplantation

  111. Ouseph R, Stoddard MF, Lederer ED (1997) Patent foramen ovale presenting as refractory hypoxemia after heart transplantation. J Am Soc Echocardiogr 10:973–976

    PubMed  Google Scholar 

  112. Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M (1990) Factors influencing the development of hypertension after heart transplantation. J Heart Transplant 9:548–553

    PubMed  Google Scholar 

  113. Pae WE, Aufiero TX, Weldner PW, Miller CA, Pierce WS (1994) Aprotinin therapy for insertion of ventricular assist devices for staged heart transplantation. J Heart Lung Transplant 13:811–816

    PubMed  Google Scholar 

  114. Palmer RM, Ferrige AG, Moncada S (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524–526

    CAS  PubMed  Google Scholar 

  115. Prendergast TW, Furukawa S, Beyer AJ, Eisen HJ, McClurken JB, Jeevanandam V (1996) Defining the role of aprotinin in heart transplantation. Ann Thorac Surg 62:670–674

    Article  PubMed  Google Scholar 

  116. Priola DV, Spurgeon HA (1977) Cholinergic sensitivity of the denervated canine heart. Circ Res 41:600–606

    PubMed  Google Scholar 

  117. Qi AZ, Tuna IC, Gornick CC et al. (1987) Potentiation of cardiac electrophysiologic effects of verapamil after autonomic blockade or cardiac transplantation. Circulation 75:888–893

    PubMed  Google Scholar 

  118. Rajek A, Pernerstorfer T, Kastner J et al. (2000) Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E(1) during heart transplantation. Anesth Analg 90:523–530

    PubMed  Google Scholar 

  119. Rakhit A, Nurko S, Gauvreau K, Mayer JE, Blume ED (2002) Gastrointestinal complications after pediatric cardiac transplantation. J Heart Lung Transplant 21:751–759

    Article  PubMed  Google Scholar 

  120. Rich S, Gubin S, Hart K (1990) The effects of phenylephrine on right ventricular performance in patients with pulmonary hypertension. Chest 98:1102–1106

    PubMed  Google Scholar 

  121. Rothman SA, Jeevanandam V, Combs WG et al. (1996) Eliminating bradyarrhythmias after orthotopic heart transplantation. Circulation 94:II278–282

    PubMed  Google Scholar 

  122. Sablotzki A, Czeslick E, Schubert S et al. (2002) Iloprost improves hemodynamics in patients with severe chronic cardiac failure and secondary pulmonary hypertension. [L'iloprost ameliore l'hemodynamique chez des malades souffrant d'insuffisance cardiaque chronique et d'hypertension arterielle pulmonaire]. Can J Anaesth 49:1076–1080

    PubMed  Google Scholar 

  123. Sablotzki A, Hentschel T, Gruenig E et al. (2002) Hemodynamic effects of inhaled aerosolized iloprost and inhaled nitric oxide in heart transplant candidates with elevated pulmonary vascular resistance. Eur J Cardiothorac Surg 22:746–752

    Article  PubMed  Google Scholar 

  124. Scherrer U, Vissing S, Morgan B et al. (1990) Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 323:693–699

    PubMed  Google Scholar 

  125. Scherrer U, Vissing S, Morgan BJ, Hanson P, Victor RG (1990) Vasovagal syncope after infusion of a vasodilator in a heart-transplant recipient. N Engl J Med 322:602–604

    PubMed  Google Scholar 

  126. Schroeder JS, Gao S-Z, Alderman EL et al. (1993) A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 328:164–170

    Google Scholar 

  127. Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K (1987) Patent foramen ovale complicating heart transplantation. A window on posttransplantation hemodynamics. Chest 92:569–572

    PubMed  Google Scholar 

  128. Shah KB, Rao TL, Laughlin S, El-Etr AA (1984) A review of pulmonary artery catheterization in 6,245 patients. Anesthesiology 61:271–275

    CAS  PubMed  Google Scholar 

  129. Shapira Y, Porter A, Wurzel M, Vaturi M, Sagie A (1998) Evaluation of tricuspid regurgitation severity: echocardiographic and clinical correlation. J Am Soc Echocardiogr 11:652–659

    CAS  PubMed  Google Scholar 

  130. Shumway NE, Dong E, Stinson EB (1969) Surgical aspects of cardiac transplantation in man. Bull N Y Acad Med 45:387–393

    PubMed  Google Scholar 

  131. Sievers HH, Weyand M, Kraatz EG, Bernhard A (1991) An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium. Thorac Cardiovasc Surg 39:70–72

    PubMed  Google Scholar 

  132. Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391–394

    PubMed  Google Scholar 

  133. Spray TL (1998) Use of aprotinin in pediatric organ transplantation. Ann Thorac Surg 65:S71–73; discussion S74–76

    Article  PubMed  Google Scholar 

  134. Srivastava R, Curtis M, Hendrickson S, Burns WH, Hosenpud JD (1999) Strain specific effects of cytomegalovirus on endothelial cells: implications for investigating the relationship between CMV and cardiac allograft vasculopathy. Transplantation 68:1568–1573

    PubMed  Google Scholar 

  135. Starling RC, Cody RJ (1990) Cardiac transplant hypertension. Am J Cardiol 65:106–111

    PubMed  Google Scholar 

  136. Steed DL, Brown B, Reilly JJ, Peitzman AB, Griffith BP, Hardesty RL, Webster MW (1985) General surgical complications in heart and heart-lung transplantation. Surgery 98:739–745

    PubMed  Google Scholar 

  137. Stewart MJ, Huwez F, Richens D, Naik S, Wheatley DJ (1996) Infective endocarditis of the tricuspid valve in an orthotopic heart transplant recipient. J Heart Lung Transplant 15:646–649

    PubMed  Google Scholar 

  138. Stinson EB, Dong E, Iben AB, Shumway NE (1969) Cardiac transplantation in man. 3. Surgical aspects. Am J Surg 118:182–187

    CAS  PubMed  Google Scholar 

  139. Stobierska-Dzierzek B, Awad H, Michler RE (2001) The evolving management of acute right-sided heart failure in cardiac transplant recipients. J Am Coll Cardiol 38:923–931

    Article  PubMed  Google Scholar 

  140. Taylor AJ, Bergin JD (1995) Cardiac transplantation for the cardiologist not trained in transplantation. Am Heart J 129:578–592

    PubMed  Google Scholar 

  141. Thomson JG (1969) Production of severe athero in a transplanted human heart. Lancet 2:1088–1092

    PubMed  Google Scholar 

  142. Tribouilloy CM, Enriquez-Sarano M, Bailey KR, Tajik AJ, Seward JB (2000) Quantification of tricuspid regurgitation by measuring the width of the vena contracta with Doppler color flow imaging: a clinical study. J Am Coll Cardiol 36:472–478

    Article  PubMed  Google Scholar 

  143. Uberfuhr P, Reichart B, Welz A et al. (1982) Report on a successful orthotopic cardiac transplantation in Germany. Klin Wochenschr 60:1435–1442

    PubMed  Google Scholar 

  144. Uretsky BF (1990) Physiology of the transplanted heart. Cardiovasc Clin 20:23–56

    PubMed  Google Scholar 

  145. Uretsky BF, Murali S, Reddy PS et al. (1987) Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76:827–834

    PubMed  Google Scholar 

  146. Verani MS, George SE, Leon CA et al. (1988) Systolic and diastolic ventricular performance at rest and during exercise in heart transplant recipients. J Heart Transplant 7:145–151

    PubMed  Google Scholar 

  147. Vlahakes GJ, Turley K, Hoffman JI (1981) The pathophysiology of failure in acute right ventricular hypertension: hemodynamic and biochemical correlations. Circulation 63:87–95

    CAS  PubMed  Google Scholar 

  148. Wadsworth R, Littler C (1996) Cardiac standstill, pulmonary artery catheterisation and left bundle branch block. Anaesthesia 51:97

    CAS  Google Scholar 

  149. Wahba A, Rothe G, Lodes H, Barlage S, Schmitz G (2001) The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function. Thorac Cardiovasc Surg 49:153–156

    Article  PubMed  Google Scholar 

  150. West LJ, Pollock-Barziv SM, Dipchand AI et al. (2001) ABO-incompatible heart transplantation in infants. N Engl J Med 344:793–800

    Google Scholar 

  151. Wittwer T, Pethig K, Struber M et al. (2001) Aerosolized iloprost for severe pulmonary hypertension as a bridge to heart transplantation. Ann Thorac Surg 71:1004–1006

    Article  PubMed  Google Scholar 

  152. Wittwer T, Franke U, Wahlers T (2002) Impact of aerosolized prostacyclin analog for severe pulmonary hypertension in thoracic organ transplantation. J Thorac Cardiovasc Surg 124:211–213

    Article  PubMed  Google Scholar 

  153. Yusuf S, Theodoropoulos S, Mathias CJ, Dhalla N, Wittes J, Mitchell A, Yacoub M (1987) Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after beta-adrenergic blockade. Circulation 75:696–704

    PubMed  Google Scholar 

  154. Zwissler B (2000) Acute right heart failure. Etiology—pathophysiology—diagnosis—therapy. Anaesthesist 49:788-808

    Article  PubMed  Google Scholar 

  155. Zwissler B (2002) Inhaled vasodilators. Anaesthesist 51:603–624

    Article  Google Scholar 

  156. Zwissler B, Rank N, Jaenicke U et al. (1995) Selective pulmonary vasodilation by inhaled prostacyclin in a newborn with congenital heart disease and cardiopulmonary bypass. Anesthesiology 82:1512–1516

    PubMed  Google Scholar 

  157. Zwissler B, Welte M, Habler O, Kleen M, Messmer K (1995) Effects of inhaled prostacyclin as compared with inhaled nitric oxide in a canine model of pulmonary microembolism and oleic acid edema. J Cardiothorac Vasc Anesth 9:634–640

    PubMed  Google Scholar 

  158. Zwissler B, Kemming G, Habler O et al. (1996) Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med 154:1671–1677

    CAS  PubMed  Google Scholar 

  159. Zwissler B, Forst H, Messmer K (1998) Influence of positive end-expiratory pressure ventilation (PEEP) on left ventricular pattern of contraction in experimental ARDS. Eur J Med Res 3:231–240

    PubMed  Google Scholar 

Download references

Danksagung

Wir danken der kardioanästhesiologischen Abteilung des Brigham and Women's Hospitals, Harvard Medical School in Boston für die Bereitstellung des umfangreichen Bildarchivs, insbesondere Joe Scott und James Bell sowie Klaus-Jürgen Eltzschig für die Erstellung der Zeichnungen zur bikavalen Technik der orthotopen Herztransplantationen.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. K. Eltzschig.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eltzschig, H.K., Zwissler, B. & Felbinger, T.W. Perioperative Aspekte der Herztransplantation. Anaesthesist 52, 678–689 (2003). https://doi.org/10.1007/s00101-003-0556-1

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-003-0556-1

Schlüsselwörter

Keywords

Navigation